Member Info for Pangolin

the DOW is up 600+ points??

double, sorry!

It's for sure the two funds are in here just for the money.

But the board has to be paid, hey! :-)

The 2 funds are indeed here just for the money, not for supporting IMM itself.

But hey, the board has to be paid! :-)

That's what puzzles me, Avion, a company with no experience at all in bringing drugs to market as a partner. Why not a real drug company? I took a small bet a few weeks ago but await further news before taking more. There is something that doesn't rhyme imo.

"Looks like its breaking upwards......news pre AGM"

Heard that more than 1000 times... :-)

As far as I can see, no experience in bringing a real drug to market.

About Avion, why didn't IMM choose a more experienced pharma to assist in P3 trial? Avion doesn't seem to me first choise, to say at least.

make conclude.

MaverickD,

I don't see what you see. No big volume, no big price jumps. What does you conclude there is news coming?

I'm not a real believer of TA but I have to admit the chart looks promising! If news was released now....

All small fry, says nothing. Waiting for ( good ) news...

From their last final results:

Post review period
– Avion strengthened advisory team for Lupuzor™ Phase III trial, including collaboration with leading lupus patient group and formation of KOLs – all senior respected consultants within lupus and autoimmune community in US/EU

@MD.J.Morgan

Reason for deal with Avion:

Need for money I suppose!

And thanks for your educated posts.

As I'm in here for only a few weeks, I wonder if there has been talks/rumours about ant takeover in the past?

Thx.

Agreed, Nolupus!

I mostly sell in anticipation of approval. Or earlier if the stock has gone up as much as I wanted.

I know, Nolupus.

If you're in here you must think it will be successful, if not better stay out. And of course this is high risk.

In the course of time, lupus has killed many one-product pharma's in their quest for a cure. Hopefully IMM will succeed.

Forget covid-19, focus on Lupus. Almost every pharma has something that 'maybe' could help against the coronavirus! If this comes in for IMM, well the better then, it would be a major surplus. But I wouldn't count on it.
On the contrary, if Lupuzor is approved it will not only be used for lupus, could be a nice surprise over a few years from now if we'll see the sales.

For each buy is a sell and vice versa. So...

As long as LUPUZOR is written as it should... : -)

Read here more than one free interpretation over the last days...